One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes.
Diabetes Metab
; 43(3): 275-279, 2017 Jun.
Article
in En
| MEDLINE
| ID: mdl-27692500
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leptin
/
Diabetes Mellitus, Type 2
/
Proprotein Convertase 9
/
Lipodystrophy
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Diabetes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2017
Type:
Article
Affiliation country:
France